Are Long COVID Programs Worth It? New Data on Health Gains and Spending
April 14, 2026
Brand Name :
Synonyms :
Class :
antiplatelet agents may enhance the adverse/toxic effect of ibritumomab tiuxetan
antiplatelet agents may enhance the adverse/toxic effect of ibritumomab tiuxetan
antiplatelet agents may enhance the adverse/toxic effect of ibritumomab tiuxetan
antiplatelet agents may enhance the adverse/toxic effect of ibritumomab tiuxetan
antiplatelet agents may enhance the adverse/toxic effect of ibritumomab tiuxetan
when both the drugs are combined, the risk or severity of adverse effects increases